57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases Conference

Scholarly Activity

related documents

An interim analysis of the Canadian power program (PEGinterferon alfa-2b prospective optimal weight-based dosing response): Consistent SVR rates across all weight categories Conferences
Exposure to ribavirin (RBV) predicts EVR and SVR in patients with HCV genotype 1 infection: Analysis of the Canadian pegasys expanded access program (EAP) Conferences